Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1619-7089
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer ; day:4 ; month:3 ; year:2022 ; pages:1-8
European journal of nuclear medicine and molecular imaging ; (4.3.2022), 1-8

Urheber
Hartrampf, Philipp E.
Weinzierl, Franz-Xaver
Buck, Andreas K.
Rowe, Steven P.
Higuchi, Takahiro
Seitz, Anna Katharina
Kübler, Hubert
Schirbel, Andreas
Essler, Markus
Bundschuh, Ralph A.
Wolf, Herta
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s00259-022-05744-6
URN
urn:nbn:de:101:1-2022053119003268142986
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:33 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Hartrampf, Philipp E.
  • Weinzierl, Franz-Xaver
  • Buck, Andreas K.
  • Rowe, Steven P.
  • Higuchi, Takahiro
  • Seitz, Anna Katharina
  • Kübler, Hubert
  • Schirbel, Andreas
  • Essler, Markus
  • Bundschuh, Ralph A.
  • Wolf, Herta
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Urinary excretion kinetics of [177Lu]Lu-PSMA-617

Urinary excretion kinetics of [177Lu]Lu-PSMA-617

Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure

Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure

Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry

Influence of sampling schedules on [177Lu]Lu-PSMA dosimetry

Improved quality control of [177Lu]Lu-PSMA I&T

Improved quality control of [177Lu]Lu-PSMA I&T

Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure

Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T

Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer

EP-0565 Safety and efficacy of [177Lu]Lu-rhPSMA-10.1 re-challenge therapy in progressive mCRPC after [177Lu] Lu-PSMA I&T therapy: preliminary results [Abstract]

EP-0565 Safety and efficacy of [177Lu]Lu-rhPSMA-10.1 re-challenge therapy in progressive mCRPC after [177Lu] Lu-PSMA I&T therapy: preliminary results [Abstract]

Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer

Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer

[177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography

[177Lu]Lu-PSMA-617 salivary gland uptake characterized by quantitative in vitro autoradiography

Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617

Tumor uptake in glioblastoma multiforme after IV injection of [177Lu]Lu-PSMA-617

Verbundene Objekte